Apligraf (R): for the treatment of diabetic foot and venous leg ulcers
Parrella, A
Record ID 32006000629
English
Authors' results and conclusions:
The quality of evidence for the use of Apligraf is high, however it is potentially biased (level II evidence, without blinding). Although this evidence indicates limited benefit to patients in the long-term, there is a lack of studies comparing Apligraf to alternative treatments. In addition, treatment with Apligraf is costly.
Authors' recommendations:
As there are alternative therapies available in the Australian health system, it is therefore recommended that this technology be archived.
Details
Project Status:
Completed
Year Published:
2004
URL for published report:
Not Available
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Skin, Artificial
- Wound Healing
- Collagen
- Diabetic Foot
- Leg Ulcer
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.